Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Amortization of Deferred Charges (2017 - 2023)

Standard Biotools has reported Amortization of Deferred Charges over the past 7 years, most recently at $173000.0 for Q4 2023.

  • Quarterly Amortization of Deferred Charges fell 14.36% to $173000.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $770000.0 through Dec 2023, down 7.23% year-over-year, with the annual reading at $770000.0 for FY2023, 7.23% down from the prior year.
  • Amortization of Deferred Charges was $173000.0 for Q4 2023 at Standard Biotools, down from $187000.0 in the prior quarter.
  • Over five years, Amortization of Deferred Charges peaked at $2.0 million in Q1 2019 and troughed at -$194000.0 in Q4 2019.
  • The 5-year median for Amortization of Deferred Charges is $194500.0 (2022), against an average of $269500.0.
  • Year-over-year, Amortization of Deferred Charges crashed 107.28% in 2019 and then skyrocketed 205.0% in 2021.
  • A 5-year view of Amortization of Deferred Charges shows it stood at -$194000.0 in 2019, then skyrocketed by 167.01% to $130000.0 in 2020, then soared by 228.46% to $427000.0 in 2021, then crashed by 52.69% to $202000.0 in 2022, then decreased by 14.36% to $173000.0 in 2023.
  • Per Business Quant, the three most recent readings for LAB's Amortization of Deferred Charges are $173000.0 (Q4 2023), $187000.0 (Q3 2023), and $206000.0 (Q2 2023).